ClearPoint Neuro, Inc. - FORM 10-K - EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - March 27, 2020

Attached files

file filename
EX-32 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND - ClearPoint Neuro, Inc.ex32.htm
10-K - ClearPoint Neuro, Inc.eps8906.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER - ClearPoint Neuro, Inc.ex31-2.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - ClearPoint Neuro, Inc.ex31-1.htm
EX-21 - LIST OF SUBSIDIARIES - ClearPoint Neuro, Inc.ex21.htm
EX-4.23 - DESCRIPTION OF THE REGISTRANT'S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF - ClearPoint Neuro, Inc.ex4-23.htm

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the inclusion or incorporation by reference of our report, dated March 27, 2020, with respect to the consolidated balance sheets of ClearPoint Neuro, Inc. (formerly, MRI Interventions, Inc.) and subsidiary (the “Company”) as of December 31, 2019 and 2018 and the related consolidated statements of operations, stockholders’ equity and cash flows for the years then ended, in (i) the Company’s Registration Statement on Form S-8 (No. 333-183382), (ii) the Company’s Registration Statement on Form S-8 (No. 333-191908), (iii) the Company’s Registration Statement on Form S-8 (No. 333-206432), and (iv) the Company’s Registration Statement on Form S-8 (No. 333-220783).

 

/s/ Cherry Bekaert LLP

 

Tampa, Florida
March 27, 2020

 

 

ClearPoint Neuro, Inc. Reports